| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total net revenue | 334,206 | 314,635 | 255,737 | 180,929 |
| Cost of revenues-Genomic | 98,643 | 99,756 | 84,783 | 60,126 |
| Cost of revenues-Data And Services | 25,621 | 19,840 | 15,751 | 14,964 |
| Technology research and development | 38,087 | 34,482 | 33,391 | 30,680 |
| Research and development | 44,960 | 41,619 | 35,874 | 27,348 |
| Selling, general and administrative | 187,891 | 180,712 | 154,627 | 101,427 |
| Total cost and operating expenses | 395,202 | 376,409 | 324,426 | 234,545 |
| Loss from operations | -60,996 | -61,774 | -68,689 | -53,616 |
| Interest income | 4,600 | 1,093 | 1,813 | 4,789 |
| Interest expense | 15,399 | 21,579 | 18,003 | 13,761 |
| Loss on debt extinguishment | -12,034 | - | - | - |
| Other income (expense), net | 2,605 | 41,729 | -27,455 | -11,522 |
| Loss before (provision for) benefit from income taxes | -81,224 | -40,531 | -112,334 | -74,110 |
| (provision for) benefit from income taxes | 276 | 212 | -46,180 | - |
| Gains (losses) from equity method investments | 1,518 | -2,100 | -1,883 | -1,692 |
| Provision for income taxes | - | - | - | 38 |
| Net loss | -79,982 | -42,843 | -68,037 | -75,840 |
| Dividends on series a, b,b-1,b-2,c, d, e, f, g,g-3,andg-4preferred shares | 0 | 0 | 0 | 0 |
| Cumulative undeclared dividends on series c preferred shares | 0 | 0 | 0 | 0 |
| Net loss attributable to common shareholders, basic | -79,982 | -42,843 | -68,037 | -75,840 |
| Earnings per share, basic | -0.46 | -0.25 | -0.4 | -0.46 |
| Earnings per share, diluted | -0.46 | -0.25 | -0.4 | -0.46 |
| Weighted average number of shares outstanding, basic | 174,945 | 173,381 | 170,506 | 165,612 |
| Weighted average number of shares outstanding, diluted | 174,945 | 173,381 | 170,506 | 165,612 |
Tempus AI, Inc. (TEM)
Tempus AI, Inc. (TEM)